Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma

The definition of asthma has changed considerably in recent years, to the extent that asthma is no longer considered a single disease but a heterogeneous disorder that includes several phenotypes and, possibly, endotypes. A more detailed analysis of the immunological mechanisms underlying the pathog...

Full description

Bibliographic Details
Main Authors: Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, Francesca Puggioni, Giovanni Passalacqua, Giorgio Walter Canonica
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Medicine
Subjects:
interleukin 5
precision medicine
personalized medicine
severe asthma
monoclonal antibodies
biomarkers
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2017.00135/full

Internet

http://journal.frontiersin.org/article/10.3389/fmed.2017.00135/full

Similar Items